Optimizing the Production of gp145, an HIV-1 Envelope Glycoprotein Vaccine Candidate and Its Encapsulation in Guanosine Microparticles

by Pearl Akamine 1, José A. González-Feliciano 1, Ruth Almodóvar 2, Gloriner Morell 2, Javier Rivera 2, Coral M. Capó-Vélez 1, Manuel Delgado-Vélez 1,3, Luis Prieto-Costas 4, Bismark Madera 1,3, Daniel Eichinger 2, Ignacio Pino 2, José H. Rivera 2, José Ortiz-Ubarri 5, José M. Rivera 4, Abel Baerga-Ortiz 1,6 and José A. Lasalde-Dominicci 1,3,4,7,*

A recombinant gp145 Env glycoprotein from HIV-1 expressed in two different cell lines: Effects on glycosylation and antigenicity

A recombinant gp145 Env glycoprotein from HIV-1 expressed in two different cell lines: Effects on glycosylation and antigenicity. González-Feliciano JA, Akamine P, Capó-Vélez CM, Delgado-Vélez M, Dussupt V, Krebs SJ, Wojna V, Polonis VR, Baerga-Ortiz A, Lasalde-Dominicci JA. PLoS One. 2020 Jun 19;15(6):e0231679. doi: 10.1371/journal.pone.0231679. eCollection 2020. PMID: 32559193.